| abstract |
The invention discloses a serum amyloid A detection kit, comprising R1 reagent, R2 reagent, diluent and calibrator. The R1 reagent includes buffer ①, coagulant, stabilizer ①, inhibitor and preservative The R2 reagent includes human recombinant serum amyloid A antibody latex particles, buffer ②, stabilizer ② and preservatives; the diluent is physiological saline with added stabilizers ③ and preservatives; the calibrator includes antigens and diluent. The present invention can effectively delay the appearance of the HOOK effect by adding an inhibitor to the R1 reagent, so that the negative and positive can be accurately judged within the routine clinical detection range (such as 0mg/L-5000mg/L), and the HOOK effect will not cause the occurrence of negative and positive results. False-negative results appear at high clinical values, affecting clinical diagnosis. |